The DOI matches its Crossref record; 78 of the 86 references it cites were found in a registry or an index.
Chk2/hCds1 functions as a DNA damage checkpoint in G1by stabilizing p53
Open accessAbstract
Chk2/hcds1, the human homolog of the Saccharomyces cerevisiae RAD53/SPK1 and Schizosaccharomyces pombe cds1 DNA damage checkpoint genes, encodes a protein kinase that is post-translationally modified after DNA damage. Like its yeast homologs, the Chk2/hCds1 protein phosphorylates Cdc25C in vitro, suggesting that it arrests cells in G 2 in response to DNA damage. We expressed Chk2/hCds1 in human cells and analyzed their cell cycle profile. Wild-type, but not catalytically inactive, Chk2/hCds1 led to G 1 arrest after DNA damage. The arrest was inhibited by cotransfection of a dominant-negative p53 mutant, indicating that Chk2/hCds1 acted upstream of p53. In vitro, Chk2/hCds1 phosphorylated p53 on Ser-20 and dissociated preformed complexes of p53 with Mdm2, a protein that targets p53 for degradation. In vivo, ectopic expression of wild-type Chk2/hCds1 led to increased p53 stabilization after DNA damage, whereas expression of a dominant-negative Chk2/hCds1 mutant abrogated both phosphorylation of p53 on Ser-20 and p53 stabilization. Thus, in response to DNA damage, Chk2/hCds1 stabilizes the p53 tumor suppressor protein leading to cell cycle arrest in G 1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and hChk2, in turn, phosphorylates yet another amino-terminal Ser residue (Ser 20) in p53”
From Cell cycle checkpoint signaling through the ATM and ATR kinases (2001) · cites this paper as Chehab et al. 2000
In the citing paper
“These phosphorylation events contribute to disrupting the p53-Mdm2 (Chehab et al., 2000; Shieh et al., 2000), and Mdm2-DAXX (Tang et al., 2013) interactions, as well as to the degradation of Mdm2 and Mdm4 (Stommel and Wahl, 2004; Chen et al., 2005; Pereg et al., 2005, 2006; LeBron et al., 2006).”
From USP7 Is a Master Regulator of Genome Stability (2020) · cites this paper as Chehab et al., 2000
In the citing paper
“ATM also activates Chk2, which in turn phosphorylates p53 on serine 20 and inhibits MDM2 binding (Shieh et al, 1997;Banin et al, 1998;Chehab et al, 2000;Shieh et al, 2000).”
From ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage (2005) · cites this paper as Chehab et al, 2000
In the citing paper
“Studies using Chk2-null mice, Chk2-null HCT116 cells, and Chk2 siRNA resulted in different conclusions (Zhang et al, 1998;Chehab et al, 2000;Shieh et al, 2000;Ahn et al, 2003; Jallepalli et al, 2003).”
From ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage (2005) · cites this paper as Chehab et al, 2000
In the citing paper
“Although a role of ATM in p53 response is well established, the significance of Chk2 is still a matter of debate.”
From ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage (2005) · cites this paper as Chehab et al, 2000
In the citing paper
“ATM also activates Chk2, which in turn phosphorylates p53 on S20, which is a part of the MDM2-binding site (Shieh et al, 1997(Shieh et al, , 2000;;Banin et al, 1998;Chehab et al, 2000).”
From ATM activates p53 by regulating MDM2 oligomerization and E3 processivity (2009) · cites this paper as Chehab et al, 2000
In the citing paper
“p53 is phosphorylated at Ser20 by the checkpoint kinase Chk2 after IR, which results in p53's dissociation from Mdm2 and its subsequent stabilization”
From USP10 Regulates p53 Localization and Stability by Deubiquitinating p53 (2010) · cites this paper as Chehab et al., 2000
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 2×
“Stabilization of p53 in cells exposed to IR or UV light is due to dissociation from Mdm2 (Shieh et al. 1997), a protein that targets p53 for degradation through the ubiquitin pathway (Haupt et al. 1997; Kubbutat et al. 1997; Midgley and Lane 1997).”
BackgroundMomand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
p53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864
A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785
Thymocyte apoptosis induced by p53-dependent and independent pathways
Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., & Wyllie, A. H. (1993) · Nature · doi:10.1038/362849a0 · Cited by 2,271
Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain
Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.948 · Cited by 2,206
Cited by
Sorted by citations
Items 501–600 of 805
Tanaka, T., Kurose, A., Huang, X., Traganos, F., Dai, W. H., & Darżynkiewicz, Z. (2006) · Cell Proliferation · doi:10.1111/j.1365-2184.2006.00387.x · Cited by 25
Pharmacogenomics and Breast Cancer
Lymberis, S. C., Parhar, P. K., Katsoulakis, E., & Formenti, S. C. (2004) · Pharmacogenomics · doi:10.1517/phgs.5.1.31.25686 · Cited by 23
Yu, J., Wilson, J. L., Taylor, L., & POLGAR, P. R. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24987 · Cited by 23
DNA Damage and Polyploidization
Chow, J. P. H., & Poon, R. Y. C. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6199-0_4 · Cited by 24
Datta, A., & Nicot, C. (2007) · Oncogene · doi:10.1038/sj.onc.1210718 · Cited by 23
Novak, D. J., Chen, L. Q., Ghadirian, P., Hamel, N., Zhang, P., Rossiny, V., Cardinal, G., Robidoux, A., Tonin, P. N., Rousseau, F., et al. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-239 · Cited by 24
Minimal role of base excision repair in TET-induced global DNA demethylation in HEK293T cells
Jin, C., Qin, T., Barton, M. C., Jelı́nek, J., & Issa, J. J. (2015) · Epigenetics · doi:10.1080/15592294.2015.1091145 · Cited by 23
Identification of mutated driver pathways in cancer using a multi-objective optimization model
Zheng, C.-H., Wu, Y., Chong, Y., & Xia, J. (2016) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2016.03.002 · Cited by 23
Lener, M. R., Kashyap, A., Kluźniak, W., Cybulski, C., Soluch, A., Pietrzak, S., Huzarski, T., Gronwald, J., & Lubiński, J. (2016) · Cancer Research and Treatment · doi:10.4143/crt.2016.217 · Cited by 23
Kim, S. S., Choo, D. W., Shin, D., Baek, H. J., Kim, T. H., Motoyama, N., Coster, B. M. D., Gueulette, J., Furusawa, Y., Andō, K., et al. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.08.010 · Cited by 23
Irofulven induces replication-dependent CHK2 activation related to p53 status
Wang, Y., Wiltshire, T. D., Senft, J., Reed, E., & Wang, W. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.10.023 · Cited by 24
Limoli, C. L., Laposa, R. R., & Cleaver, J. E. (2002) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(02)00257-9 · Cited by 23
Koledova, Z. S., Kafkova, L. R., Krämer, A., & Divoký, V. (2010) · Stem Cells · doi:10.1002/stem.311 · Cited by 26
Mammalian DNA Damage Response Pathway
Lou, Z., & Chen, J. (2006) · Springer eBooks · doi:10.1007/1-4020-3764-3_15 · Cited by 19
Yan, F., Liu, H., & Liu, Z. (2013) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2013.06.022 · Cited by 22
The phenotype of MDM2 auto-degradation after DNA damage is due to epitope masking by phosphorylation
Cheng, Q., & Chen, J. (2011) · Cell Cycle · doi:10.4161/cc.10.7.15249 · Cited by 21
Chen, S., Shao, F., Zeng, J., Guo, S., Wang, L., Sun, H., Lei, J. H., Lyu, X., Gao, S., Chen, Q., et al. (2023) · Science Advances · doi:10.1126/sciadv.abq1395 · Cited by 21
Liang, X., Guo, Y., Figg, W. D., Fojo, A. T., Mueller, M. D., & Yu, J. (2010) · Chemotherapy Research and Practice · doi:10.1155/2011/715469 · Cited by 23
ATM and Chk2 kinase target the p53 cofactor Strap
Adams, C., Graham, A., Jansson, M., Coutts, A. S., Edelmann, M. J., Smith, L. M., Kessler, B. M., & Thangue, N. B. L. (2008) · EMBO Reports · doi:10.1038/embor.2008.186 · Cited by 21
ATM in focus: A damage sensor and cancer target
Khalil, H. S., Tummala, H., & Zhelev, N. (2012) · Biodiscovery · doi:10.7750/biodiscovery.2012.5.1 · Cited by 23
Upton, B., Chu, Q. D., & Li, B. D. �. (2008) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2008.08.006 · Cited by 21
Zhang, Y., Chen, G., Gu, Z., Sun, H., Karaplis, A. C., Goltzman, D., & Miao, D. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.23318 · Cited by 21
p53 in a Crosstalk Between DNA Repair and Cell Cycle Checkpoints
Okorokov, A. L. (2003) · Cell Cycle · doi:10.4161/cc.2.3.394 · Cited by 21
Absence of CHEK2*1100delC mutation in families with hereditary breast cancer in North America
Iniesta, M. D., Gorin, M. A., Chien, L.-C., Thomas, S. M., Milliron, K. J., Douglas, J. A., & Merajver, S. D. (2010) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2010.07.124 · Cited by 21
Liu, J., Cao, L., Wang, Y., Zou, Y. F., Guo, Q., Chen, S., Jiang, B., Wu, X., Zheng, L., Zhang, S., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114366 · Cited by 20
The p53 Tumor Suppressor Pathway and Cancer
Zambetti, G. P. (2005) · Springer eBooks · doi:10.1007/0-387-30127-5 · Cited by 20
Analysis of CHK2 in patients with myelodysplastic syndromes
Aktaş, D., Arno, M. J., Rassool, F. V., & Mufti, G. J. (2002) · Leukemia Research · doi:10.1016/s0145-2126(02)00075-9 · Cited by 20
Regulation of p53-dependent transcription
Jõers, A. (2004) · DSpace repository (University of Tartu) · Cited by 20
Mukhtar, T. K., Wilcox, N., Dennis, J., Yang, X., Naven, M., Mavaddat, N., Perry, J. R. B., Gardner, E. J., & Easton, D. F. (2024) · Journal of Medical Genetics · doi:10.1136/jmg-2024-110127 · Cited by 20
Zhao, H., Li, S., Huang, W., Liu, J., Yuan, D., Wang, Y., & Zhang, C. (2017) · Andrologia · doi:10.1111/and.12756 · Cited by 20
Identification of a Novel Isoform of iASPP and its Interaction with p53
Zhang, X., Diao, S., Rao, Q., Xing, H., Liu, H., Liao, X., Wang, M., & Wang, J. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.03.001 · Cited by 19
Huang, S. H., Qu, L., Cuddihy, A. R., Ragheb, R., Taya, Y., & Koromilas, A. E. (2003) · Oncogene · doi:10.1038/sj.onc.1206490 · Cited by 19
Zeng, X., Zhu, Y., & Lu, H. (2001) · Carcinogenesis · doi:10.1093/carcin/22.2.215 · Cited by 19
Absence of Germline CHK2 Mutations in Familial Gastric Cancer
Kimura, K., Shinmura, K., Yoshimura, K., Shimizu, K., Katai, H., Beppu, Y., Moriya, H., & Yokota, J. (2000) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2000.tb01028.x · Cited by 19
Shen, L. H., Zhang, S., Wang, K., & Wang, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.740227 · Cited by 21
Jang, E. R., Lee, J. H., Lim, D., & Lee, J. (2004) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-003-0522-y · Cited by 17
Chek2 DNA Damage Response Pathway and Inherited Breast Cancer Risk
Tung, N., & Silver, D. P. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.1476 · Cited by 17
Cellular‐signaling pathways unveil the carcinogenic potential of chemicals
Hendriks, G., van de Water, B., Schoonen, W. G. E. J., & Vrieling, H. (2013) · Journal of Applied Toxicology · doi:10.1002/jat.2845 · Cited by 18
CHK2 Promotes Anoikis and is Associated with the Progression of Papillary Thyroid Cancer
Zhao, W., Chen, S., Hou, X., Chen, G., & Zhao, Y. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000487724 · Cited by 18
Quantitative Profiling of DNA Damage and Apoptotic Pathways in UV Damaged Cells Using PTMScan Direct
Stokes, M. P., Silva, J. C., Jia, X., Lee, K., Polakiewicz, R. D., & Comb, M. J. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms14010286 · Cited by 18
Chan, W. M., & Poon, R. Y. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3602 · Cited by 19
Sasaki, K., Yamagata, T., & Mitani, K. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2007.00699.x · Cited by 18
Synthesis and biological evaluation of heteroaryl styryl sulfone derivatives as anticancer agents
Long, Y., Yu, M., Li, P., Islam, S., Goh, A. W., Kumarasiri, M., & Wang, S. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.10.062 · Cited by 18
Chk2 regulates transcription-independent p53-mediated apoptosis in response to DNA damage
Chen, C., Shimizu, S., Tsujimoto, Y., & Motoyama, N. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.126 · Cited by 18
Promyelocytic leukemia protein-induced growth suppression and cell death in liver cancer cells
Son, S., Yu, E., Choi, E. K., Lee, H., & Choi, J. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700755 · Cited by 18
Tumor Suppression by p53 in the Absence of Atm
Bailey, S. L., Gurley, K. E., Hoon-Kim, K., Kelly‐Spratt, K. S., & Kemp, C. J. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-2009 · Cited by 18
Mammary Tumorigenesis following Transgenic Expression of a Dominant Negative CHK2 Mutant
Kwak, E. L., Kim, S., Zhang, J., Cardiff, R. D., Schmidt, E. V., & Haber, D. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1237 · Cited by 18
Boyle, J. M., Spreadborough, A. R., Greaves, M. J., Birch, J. M., Varley, J. M., & Scott, D. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1896 · Cited by 18
DNA Damage Induces p53-dependent Down-regulation of hCHK1
Damia, G. L. M., Sánchez, Y., Erba, E., & Broggini, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007178200 · Cited by 18
Li, C., Bai, J., Hao, X., Zhang, S., Hu, Y., Zhang, X., Yuan, W., Hu, L., Cheng, T., Zetterberg, A., et al. (2014) · Cell Cycle · doi:10.4161/cc.28201 · Cited by 17
Germline mutations in a DNA repair pathway are associated with familial colorectal cancer
Xu, P., Sun, D., Gao, Y., Jiang, Y., Zhong, M., Zhao, G., Chen, J., Wang, Z., Liu, Q., Hong, J., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.148931 · Cited by 17
PTEN, Longevity and Age-Related Diseases
Tait, I., Li, Y., & Lu, J. (2013) · Biomedicines · doi:10.3390/biomedicines1010017 · Cited by 17
Cummings, M., Siitonen, T., Higginbottom, K., Newland, A. C., & Allen, P. D. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03262.x · Cited by 18
Leblanc, V., Delaunay, V., Lelong, J., Gas, F., Mathis, G., Grassi, J. J., & May, E. (2002) · Analytical Biochemistry · doi:10.1016/s0003-2697(02)00229-4 · Cited by 17
de Jong, M. M., Nolte, I. M., Meerman, G. J. T., van der Graaf, W. T. A., Oosterom, E., Bruinenberg, M., van der Steege, G., Oosterwijk, J. C., van der Hout, A. H., Boezen, H. M., et al. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.04.035 · Cited by 17
Wagenius, M., Borg, Å., Johansson, L., Giwercman, A., & Ola Bratt, A. (2006) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/00365590500368518 · Cited by 17
ATM: Sounding the Double-strand Break AlarmPreprint
Shiloh, Y. (2000) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2000.65.527 · Cited by 17
García‐Santisteban, I., Llopis, A., Krenning, L., Vallejo-Rodríguez, J., van den Broek, B., Zubiaga, A. M., & Medema, R. H. (2021) · BMC Biology · doi:10.1186/s12915-021-00965-x · Cited by 16
Hublarová, P., Greplová, K., Holčáková, J., Vojtěšek, B., & Hrstka, R. (2010) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-010-0021-5 · Cited by 15
Balmer, M. T., Katz, R. D., Liao, S., Goodwine, J. S., & Gal, S. (2014) · Cancer Biology & Therapy · doi:10.4161/cbt.29112 · Cited by 16
Hwang, S. J., Cha, J. Y., Park, S. G., Joe, G. J., Kim, H. M., Moon, H. B., Jeong, S. J., Lee, J. S., Shin, D. H., Ko, S. R., et al. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2002.9413 · Cited by 16
Immune diversity and genomic stability: opposite goals but similar paths
Jeggo, P. A., & CONCANNON, P. J. (2001) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/s1011-1344(01)00243-3 · Cited by 16
Germline CHEK2*1100delC mutations in breast cancer patients with multiple primary cancers
Huang, J., Domchek, S. M., Brose, M. S., Rebbeck, T. R., Nathanson, K. L., & Weber, B. L. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.022913 · Cited by 15
The key vulnerabilities and therapeutic opportunities in the USP7-p53/MDM2 axis in cancer
Saha, G., & Ghosh, M. K. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2025.119908 · Cited by 18
Mutagenic Consequences of Sublethal Cell Death Signaling
Hawkins, C. J., & Miles, M. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116144 · Cited by 15
The Role of E3 Ligase Pirh2 in Disease
Daks, A. A., Fedorova, O., Parfenyev, S. E., Nevzorov, I. A., Shuvalov, O. Y., & Barlev, N. A. (2022) · Cells · doi:10.3390/cells11091515 · Cited by 19
Qin, S., Kitty, I., Hao, Y., Zhao, F., & Kim, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210212 · Cited by 14
Gene expression patterns in heterozygous Plk4 murine embryonic fibroblasts
Morettin, A., Ward, A., Nantais, J., & Hudson, J. W. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-319 · Cited by 15
Gu, H., Qiu, W., Wan, Y., Ding, G., Tang, W., Liu, C., Shi, Y., Chen, Y., & Chen, S. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-1410-1 · Cited by 14
Lu, C.-C., Lin, M., Chen, S.-Y., Shen, C., Chen, L.-G., Hsieh, H., Chan, M. W., & Hsu, C. (2013) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-13-44 · Cited by 15
Zhang, Q. H., Song, L., Huo, X., Wang, L., Zhang, G.-B., Hao, S., Jia, H.-W., Kong, C.-L., Jia, W., Wu, Z., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01441 · Cited by 15
Correlation between Oncogenic Mutations and Parameter Sensitivity of the Apoptosis Pathway Model
Chen, J., Yue, H., & Ouyang, Q. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003451 · Cited by 15
DNA damage checkpoints in nasopharyngeal carcinoma
Poon, R. Y. C. (2014) · Oral Oncology · doi:10.1016/j.oraloncology.2014.01.009 · Cited by 15
Cell-cycle Alterations in Post-mitotic Cells and Cell Death by Mitotic Catastrophe
Lombardi, D., & Lasagni, L. (2016) · InTech eBooks · doi:10.5772/61783 · Cited by 16
Case Report of an Adrenocortical Carcinoma Associated With Germline CHEK2 Mutation
Xie, C., Tanakchi, S., Raygada, M. J., Davis, J. L., & Rivero, J. D. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00343 · Cited by 15
A modified p53 enhances apoptosis in sarcoma cell lines mediated by doxorubicin
Tang, H.-J., Qian, D., Sondak, V. K., Stachura, S. V., & Lin, J. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601653 · Cited by 15
Kaufmann, W. K., Filatov, L. V., Oglesbee, S. E., Simpson, D. A., Lotano, M. A., McKeen, H. D., Sawyer, L., Moore, D. T., Millikan, R. C., Cordeiro‐Stone, M., et al. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl103 · Cited by 14
Chromosomal radiosensitivity of breast cancer with a mutation
Baeyens, A., Claes, K., Willems, P. H. G. M., DERUYCK, K., Thierens, H. M., & Vral, A. (2005) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2005.04.017 · Cited by 15
Disrupting the p53-mdm2 interaction as a potential therapeutic modality
Moll, U. M., & Zaika, A. (2000) · Drug Resistance Updates · doi:10.1054/drup.2000.0160 · Cited by 15
Beardsley, D. I., Kim, W.-J., & Brown, K. D. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.013888 · Cited by 15
The FHA Domain, a Phosphoamino Acid Binding Domain Involved in the DNA Damage Response PathwayPreprint
Huang, M., & Elledge, S. J. (2000) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2000.65.413 · Cited by 15
Tedaldi, G., Danesi, R., Zampiga, V., Tebaldi, M., Bedei, L., Zoli, W., Amadori, D., Falcini, F., & Calistri, D. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-478 · Cited by 14
Comparative assessment of the functional p53 status in glioma cells.
Kim, E. L., Yoshizato, K., Kluwe, L., Meissner, H., Warnecke, G., Zapf, S., Westphal, M., Deppert, W., & Giese, A. (2005) · PubMed · Cited by 14
Abramowitz, J., Neuman, T., Perlman, R., & Ben‐Yehuda, D. (2017) · BMC Medical Genomics · doi:10.1186/s12920-017-0249-2 · Cited by 14
Richardson, E., Stockwell, S. R., Li, H., Aherne, W., Cuomo, M. E., & Mittnacht, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031627 · Cited by 13
Tumor suppressor protein kinase Chk2 is a mediator of anoikis of intestinal epithelial cells
Yoo, B. H., Berezkin, A., Wang, Y., Zagryazhskaya, A., & Rosen, K. V. (2011) · International Journal of Cancer · doi:10.1002/ijc.26368 · Cited by 14
A spatiotemporal characterization of the effect of p53 phosphorylation on its interaction with MDM2
ElSawy, K. M., Sim, A. Y. L., Lane, D. P., Verma, C. S., & Caves, L. S. D. (2015) · Cell Cycle · doi:10.4161/15384101.2014.989043 · Cited by 14
dRTEL1 is Essential for the Maintenance of Germline Stem Cells
Yang, Y., Kong, R., Goh, F. G., Somers, W. G., Hime, G. R., Li, Z., & Cai, Y. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1009834 · Cited by 12
DNA Damage Response and Mismatch Repair Gene Defects in Advanced and Metastatic Prostate Cancer
Akhoundova, D., Francica, P., Rottenberg, S., & Rubin, M. A. (2023) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000422 · Cited by 13
Mills, M., Emori, C., Kumar, P., Boucher, Z., George, J., & Bolcun-Filas, E. (2025) · Developmental Biology · doi:10.1016/j.ydbio.2024.09.007 · Cited by 12
Analysis of gene expression induced by microtubule-disrupting agents in HeLa cells using microarray
Cho, S., Sihn, C., Yoo, S. J., Cho, K. K., Lee, H., Choi, Y., & Kim, S. H. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.10.015 · Cited by 11
Analysis of p53 Gene Alterations in Cancer: A Critical View
Soussi, T. (2005) · Springer eBooks · doi:10.1007/978-1-4020-2922-6_12 · Cited by 14
Borrero, L. J. H., Dicker, D. T., Santiago, J., Sanders, J. A., Tian, X., Ahsan, N., Lev, A., Zhou, L., & El‐Deiry, W. S. (2021) · eLife · doi:10.7554/elife.70429 · Cited by 11
Yuan, J., Tang, W., Luo, K., Chen, X., Gu, X., Wan, B., & Yu, L. (2006) · Molecular Biology Reports · doi:10.1007/s11033-006-6273-5 · Cited by 11
Higashiguchi, M., Nagatomo, I., Kijima, T., Morimura, O., Miyake, K., Minami, T., Koyama, S., Hirata, H., Iwahori, K., Takimoto, T., et al. (2016) · FEBS Letters · doi:10.1002/1873-3468.12449 · Cited by 11
Abnormal stability of wild-type p53 protein in a human lung carcinoma cell line
Yamauchi, M., Suzuki, K., Kodama, S., & Watanabe, M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.174 · Cited by 11
Vitale, I., Antoccia, A., Crateri, P., Leone, S., Arancia, G., & Tanzarella, C. (2005) · APOPTOSIS · doi:10.1007/s10495-005-2948-y · Cited by 12
Williams, T. M., Galbán, S., Li, F., Heist, K., Galbán, C. J., Lawrence, T. S., Holland, E. C., Thomae, T. L., Chenevert, T. L., Rehemtulla, A., et al. (2013) · Translational Oncology · doi:10.1593/tlo.13214 · Cited by 11
BRCA1: an emerging role in the cellular response to DNA damage
Haber, D. A. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02371-0 · Cited by 11
Case report: Two sisters with a germline CHEK2 variant and distinct endocrine neoplasias
Vallera, R. D., Ding, Y., Hatanpaa, K. J., Bishop, J. A., Mirfakhraee, S., Alli, A. A., Tevosian, S. G., Tabebi, M., Gimm, O., Söderkvist, P., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1024108 · Cited by 11
Metadata
- Authors
- Chehab, N. H., Malikzay, A., Appel, M., & Halazonetis, T. D.
- Affiliations
- The Wistar Institute (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2000-02-01
- Volume
- 14
- Issue
- 3
- Pages
- 278-288
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC316357
- OpenAlex
- W2131833681
- Cited by
- 805
- References
- 86
- Citations by year
- 2026: 8 · 2025: 5 · 2024: 8 · 2023: 11 · 2022: 19 · 2021: 17 · 2020: 18 · 2019: 11 · 2018: 11 · 2017: 10 · 2016: 25 · 2015: 16 · 2014: 28 · 2013: 27 · 2012: 29
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Cancer Society
- National Institutes of Health (CA-25874)
- National Cancer Institute (CA09171, CA-25874, CA-76367, R01CA076367, P01CA025874, T32CA009171)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- Chk2, DNA damage checkpoint, p53 stabilization, MDM2, G1 cell cycle arrest, Cdc25C phosphorylation, post-translational modification, tumor suppressor proteins, dominant-negative mutant
- MeSH terms
- DNA Damage, Humans, Nuclear Proteins, Phosphorylation, Protein Kinases, Proto-Oncogene Proteins, Tumor Cells, Cultured, Tumor Suppressor Protein p53, G1 Phase, Protein Serine-Threonine Kinases, Schizosaccharomyces pombe Proteins, Proto-Oncogene Proteins c-mdm2, Checkpoint Kinase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
